Consider the following $2020$ data for several pharmaceutical firms $($$ millions$).($None of the firms reported the proceeds from disposals of property, plant, and equipment.$)$

Average Cash from Expenditures

Current Liabilities Operations on PPE

Merck & Co$.,$ Inc. $$24,774$ $$10,253$ $$4,684$

Pfizer Inc. $31,61214,4032,252$

Abbott Laboratories $11,3857,9012,177$

Johnson & Johnson $39,22923,5363,347$

a$.$ Compute the operating cash flow to current liabilities $($OCFCL$)$ ratio for each firm.

Company Numerator $-$: Denominator $=$ Result

Merck & Co$.,$ Inc. Answer $1$

$0$

$-$: Answer $2$

$0$

$=$

Pfizer Inc. Answer $3$

$0$

$-$: Answer $4$

$0$

$=$

Abbott Laboratories Answer $5$

$0$

$-$: Answer $6$

$0$

$=$

Johnson & Johnson Answer $7$

$0$

$-$: Answer $8$

$0$

$=$

b$.$ Compute the free cash flow for each firm.

Company $?-?=$ Result

Merck & Co$.,$ Inc. Answer $9$

$0$

$-$ Answer $10$

$0$

$=$

$0$

Pfizer Inc. Answer $11$

$0$

$-$ Answer $12$

$0$

$=$

$0$

Abbott Laboratories Answer $13$

$0$

$-$ Answer $14$

$0$

$=$

$0$

Johnson & Johnson Answer $15$

$0$

$-$ Answer $16$

$0$

$=$

$0$

c$.$ Comment on the results of your computations.

Answer $17$

of the firms have sufficient cash flow to cover their current liabilities. All of the companies have Answer $18$

free cash flow that could be invested or returned to shareholders in the form of dividends or stock repurchases.